Bragar Eagel & Squire, P.C Continues Investigations on Behalf of PetMed, GeneDx, Lineage, and Proficient Auto and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS), GeneDx (WGS), Lineage (LINE), or Proficient Auto (PAL) To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against PetMed (PETS), GeneDx (WGS), Lineage (LINE), and Proficient Auto (PAL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
PetMed Express, Inc. (NASDAQ: PETS)
On June 10, 2025, PetMed issued a press release "announc[ing] it is delaying the release of the Company's fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process."
On this news, PetMed's stock price fell $0.47 per share, or 11.22%, to close at $3.72 per share on June 11, 2025.
For more information on the SelectQuote investigation go to: https://bespc.com/cases/PETS
GeneDx Holdings Corp. (NASDAQ:WGS)
On February 5, 2025, Grizzly Research ("Grizzly") published a report entitled "Insiders Attest That GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud". The Grizzly report asserted, among other things, that GeneDx's "growth is largely an illusion, driven by fraudulent schemes and illegal tactics deliberately aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue"; that "[t]estimonies from former employees and ongoing litigation suggest that GeneDx has inflated its revenue through an illegal practice known as ‘code stacking'", which "enables the company to bill insurance providers for services that do not meet the required criteria"; and that "CEO Katherine Stueland and CFO Kevin Feeley have consistently sold their shares immediately upon vesting, without ever engaging in open market purchases", a "pattern suggest[ing] that insiders may be aware of an imminent risk that will significantly impact the company."
On this news, GeneDx's stock price fell $4.84 per share, or 6.72%, to close at $67.18 per share on February 5, 2025.
For more information on the Cleveland-Cliffs investigation go to: https://bespc.com/cases/WGS
Lineage, Inc. (NASDAQ:LINE)
On April 30, 2025, Lineage reported first quarter 2025 financial results, including that “[t]otal revenue decreased (2.7)%” to $1.29 billion for the quarter. The Company stated it “experienced more normal seasonal trends in the first quarter after multiple years of elevated inventory levels.”
On this news, Lineage’s stock price fell $8.26, or 14.62%, to close at $48.23 per share on April 30, 2025, thereby injuring investors.
For more information on the Lineage investigation go to: https://bespc.com/cases/LINE
Proficient Auto Logistics, Inc. (NASDAQ:PAL)
On May 7, 2025, Proficient Auto announced financial results for its first quarter ended March 31, 2025, revealing that the Company had suffered a 0.4% year-over-year decrease in total operating revenue to $95.2 million and total operating loss of $2.4 million during the quarter.
On this news, Proficient Auto's stock price fell $0.40 per share, or 4.93%, to close at $7.72 per share on May 8, 2025.
For more information on the Semler investigation go to: https://bespc.com/cases/PAL
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
